BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology
- 6 May 2021
- journal article
- abstracts
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 27 (5), 851-861
- https://doi.org/10.1038/s41591-021-01304-x
Abstract
Langerhans cell histiocytosis (LCH) is a potentially fatal condition characterized by granulomatous lesions with characteristic clonal mononuclear phagocytes (MNPs) harboring activating somatic mutations in mitogen-activated protein kinase (MAPK) pathway genes, most notably BRAFV600E. We recently discovered that the BRAFV600E mutation can also affect multipotent hematopoietic progenitor cells (HPCs) in multisystem LCH disease. How the BRAFV600E mutation in HPCs leads to LCH is not known. Here we show that enforced expression of the BRAFV600E mutation in early mouse and human multipotent HPCs induced a senescence program that led to HPC growth arrest, apoptosis resistance and a senescence-associated secretory phenotype (SASP). SASP, in turn, promoted HPC skewing toward the MNP lineage, leading to the accumulation of senescent MNPs in tissue and the formation of LCH lesions. Accordingly, elimination of senescent cells using INK-ATTAC transgenic mice, as well as pharmacologic blockade of SASP, improved LCH disease in mice. These results identify senescent cells as a new target for the treatment of LCH.This publication has 37 references indexed in Scilit:
- Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cellsBlood Advances, 2020
- Langerhans-Cell HistiocytosisThe New England Journal of Medicine, 2018
- Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cellsBlood, 2017
- Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adultsBlood, 2017
- Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosisBlood, 2016
- Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesisBlood, 2014
- BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groupsThe Journal of Experimental Medicine, 2014
- Recurrent BRAF mutations in Langerhans cell histiocytosisBlood, 2010
- Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cellsNature Reviews Immunology, 2008
- Incidence of Langerhans cell histiocytosis in children: A population‐based studyPediatric Blood & Cancer, 2008